| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/14651858.CD011141.PUB2 |
| P932 | PMC publication ID | 6517240 |
| P2093 | author name string | Guanghui Ji | |
| Wenlong Tan | |||
| Xiaofei Ye | |||
| Yanfang Qian | |||
| Zhi Rui Zhou | |||
| P2860 | cites work | Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases | Q24200466 |
| New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 | ||
| Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer | Q29620301 | ||
| Management of single brain metastasis: a practice guideline | Q33294727 | ||
| The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline | Q33599104 | ||
| The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline | Q33599118 | ||
| Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy | Q34547495 | ||
| Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm | Q34632917 | ||
| Treatment of brain metastases from lung cancer: chemotherapy. | Q35955545 | ||
| Current management of brain metastases, with a focus on systemic options | Q36246183 | ||
| Therapeutic advances in the treatment of brain metastases. | Q36752650 | ||
| Systemic therapy for lung cancer brain metastases: a rationale for clinical trials | Q37137777 | ||
| The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline | Q37644237 | ||
| Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial | Q37646794 | ||
| Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial | Q38406445 | ||
| Epidemiology of brain tumors: the national survey of intracranial neoplasms | Q44515944 | ||
| Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis. | Q44610961 | ||
| Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer. | Q45919728 | ||
| The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. | Q48092999 | ||
| Brain metastases as the primary site of relapse in two randomized phase III pemetrexed trials in advanced non-small-cell lung cancer | Q48954751 | ||
| Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer | Q73236346 | ||
| P433 | issue | 12 | |
| P921 | main subject | brain metastasis | Q1620196 |
| P577 | publication date | 2018-12-04 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Chemotherapy for newly diagnosed inoperable brain metastases from non‐small cell lung cancer | |
| P478 | volume | 2018 |
Search more.